RecruitingNCT06472804

Insomnia in Patients With Metastatic Lung Cancer

Insomnia in Patients With Metastatic Non Small Cell Lung Cancer


Sponsor

Mayo Clinic

Enrollment

60 participants

Start Date

Jun 19, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

This study evaluates how common insomnia (difficulties with sleep) is in patients with lung cancer that has spread from where it first started (primary site) to other places in the body.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at insomnia (trouble sleeping) in people with metastatic non-small cell lung cancer (lung cancer that has spread to other parts of the body). Researchers want to better understand how common sleep problems are in this group, how they affect quality of life, and what might help. **You may be eligible if...** - You have been diagnosed with metastatic non-small cell lung cancer - You are receiving your 1st, 2nd, or 3rd round of treatment, or are on maintenance therapy - You are older than 18 years old **You may NOT be eligible if...** - Your cancer is considered advanced and terminal - You have severe depression or another psychiatric disorder - You have a sleep disorder other than insomnia (such as sleep apnea or restless leg syndrome) - You regularly take certain psychiatric medications (other than sleep aids) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-Interventional Study

Non-interventional study


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06472804


Related Trials